Search

Your search keyword '"Marcatti, M"' showing total 249 results
Start Over Author "Marcatti, M"
249 results on '"Marcatti, M"'

2. Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature

Author

Farina, Francesca, primary, Ferla, V., additional, Marktel, S., additional, Clerici, D., additional, Mastaglio, S., additional, Perini, T., additional, Oltolini, C., additional, Greco, R., additional, Aletti, F., additional, Assanelli, A., additional, Lupo-Stanghellini, M. T., additional, Bernardi, M., additional, Corti, C., additional, Ciceri, F., additional, and Marcatti, M., additional

Published
2022
Full Text
View/download PDF

3. Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

Author

Russo D., Polverelli N., Malagola M., Farina M., Leoni A., Bernardi S., Mammoliti S., Sacchi N., Martino M., Ciceri F., Zallio F., Olivieri A., Falcioni S., Storti G., Michieli M., Carluccio P., Grassi A., Oldani E., Bonifazi F., Prete A., Cavattoni I. M., Maffeis M., Pastore D., Vacca A., Caravelli D., Mirabile M., Mordini N., Nozzoli C., Faraci M., Federico V., Ronconi S., Skert C., Onida F., Marcatti M., Piemontese S., Narni F., Balduzzi A., De Simone G., Picardi A., De Gobbi M., Calore E., Tringali S., Zecca M., Secondino S., Guiducci B., Pelosini M., Zuffa E., Facchini L., Imola M., Iori A. P., Proia A., Sica S., Armiento D., Carella A. M., Dellacasa C. M., Fagioli F., Rabusin M., Ferrario A., Elice F., Russo, D, Polverelli, N, Malagola, M, Farina, M, Leoni, A, Bernardi, S, Mammoliti, S, Sacchi, N, Martino, M, Ciceri, F, Zallio, F, Olivieri, A, Falcioni, S, Storti, G, Michieli, M, Carluccio, P, Grassi, A, Oldani, E, Bonifazi, F, Prete, A, Cavattoni, I, Maffeis, M, Pastore, D, Vacca, A, Caravelli, D, Mirabile, M, Mordini, N, Nozzoli, C, Faraci, M, Federico, V, Ronconi, S, Skert, C, Onida, F, Marcatti, M, Piemontese, S, Narni, F, Balduzzi, A, De Simone, G, Picardi, A, De Gobbi, M, Calore, E, Tringali, S, Zecca, M, Secondino, S, Guiducci, B, Pelosini, M, Zuffa, E, Facchini, L, Imola, M, Iori, A, Proia, A, Sica, S, Armiento, D, Carella, A, Dellacasa, C, Fagioli, F, Rabusin, M, Ferrario, A, Elice, F, Russo, D., Polverelli, N., Malagola, M., Farina, M., Leoni, A., Bernardi, S., Mammoliti, S., Sacchi, N., Martino, M., Ciceri, F., Zallio, F., Olivieri, A., Falcioni, S., Storti, G., Michieli, M., Carluccio, P., Grassi, A., Oldani, E., Bonifazi, F., Prete, A., Cavattoni, I. M., Maffeis, M., Pastore, D., Vacca, A., Caravelli, D., Mirabile, M., Mordini, N., Nozzoli, C., Faraci, M., Federico, V., Ronconi, S., Skert, C., Onida, F., Marcatti, M., Piemontese, S., Narni, F., Balduzzi, A., De Simone, G., Picardi, A., De Gobbi, M., Calore, E., Tringali, S., Zecca, M., Secondino, S., Guiducci, B., Pelosini, M., Zuffa, E., Facchini, L., Imola, M., Iori, A. P., Proia, A., Sica, S., Armiento, D., Carella, A. M., Dellacasa, C. M., Fagioli, F., Rabusin, M., Ferrario, A., and Elice, F.

Subjects
Homologous, Myeloid, medicine.medical_specialty, 2019-20 coronavirus outbreak, Bone marrow transplant, Coronavirus disease 2019 (COVID-19), Epidemiology, medicine.medical_treatment, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Hematopoietic stem cell transplantation, Acute, Humans, Italy, Pandemics, RNA, Viral, SARS-CoV-2, Stem Cell Transplantation, Transplantation, Homologous, COVID-19, Hematopoietic Stem Cell Transplantation, Leukemia, Myeloid, Acute, Article, hematopoietic stem cell transplantation, covid-19, pandemic, Internal medicine, Pandemic, medicine, Viral, Acute leukemia, Transplantation, Leukemia, business.industry, Hematology, Stem-cell research, RNA, Stem cell, business
Abstract

The Transplant Centers belonging to Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO) conducted a survey with the aim of evaluating the effect of SARS-CoV2 pandemic on the allogeneic transplant activity in Italy. The pandemic period from 1/3/2020 to 31/7/2020 was compared with the same period in 2019. Overall, in 2020 there was a 2.4% reduction in the number of allo-HCT cases compared to 2019. Interestingly, this deflection did not affect the acute leukemia cases (+5.7% in 2020). The use of peripheral blood-derived stem cells (+10.7%) and cryopreservation (97.4% of the centers) was highly adopted in 2020. Despite the sanitary emergency, almost all of the surveyed centers declared no impact of SARS-CoV2 pandemic on the transplant timing and outcomes, and the sanitary policy was positively evaluated by the majority of centers. The emergency measures ensured that only a minority of the allo-HCT patients had been infected by SARS-CoV2; however, a mortality of 42.1% among the allo-HCT patients hospitalized for COVID-19 was recorded. This survey gives us the information that the GITMO Group reacted positively to the pandemic. Thanks to the emergency strategies, the Italian allo-HCT activity continued safely, showing only a minor deflection and offering the same probability of cure to the transplanted patients.

Published
2021

4. Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation

Author

Crucitti, L, Crocchiolo, R, Toffalori, C, Mazzi, B, Greco, R, Signori, A, Sizzano, F, Chiesa, L, Zino, E, Lupo Stanghellini, M T, Assanelli, A, Carrabba, M G, Marktel, S, Marcatti, M, Bordignon, C, Corti, C, Bernardi, M, Peccatori, J, Bonini, C, Fleischhauer, K, Ciceri, F, and Vago, L

Published
2015
Full Text
View/download PDF

5. Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors

Author

Peccatori, J, Forcina, A, Clerici, D, Crocchiolo, R, Vago, L, Stanghellini, M T L, Noviello, M, Messina, C, Crotta, A, Assanelli, A, Marktel, S, Olek, S, Mastaglio, S, Giglio, F, Crucitti, L, Lorusso, A, Guggiari, E, Lunghi, F, Carrabba, M, Tassara, M, Battaglia, M, Ferraro, A, Carbone, M R, Oliveira, G, Roncarolo, M G, Rossini, S, Bernardi, M, Corti, C, Marcatti, M, Patriarca, F, Zecca, M, Locatelli, F, Bordignon, C, Fleischhauer, K, Bondanza, A, Bonini, C, and Ciceri, F

Published
2015
Full Text
View/download PDF

15. UNRELATED CORD BLOOD TRANSPLANTATION IN ADULTS WITH PRIMARY AND SECONDARY MYELOFIBROSIS: A RETROSPECTIVE STUDY ON BEHALF OF EUROCORD AND CMWP-EBMT: PH-O107

Author

Giannotti, F., Ruggeri, A., Deconinck, E., Mohty, M., Michallet, M., Sanz, G., Chevallier, P., Cahn, J.-Y., Legrand, F., Rovira, M., Passweg, J., Cornelissen, J. J., Sierra, J., Nguyen, S., Maillard, N., Yakoub-Agha, I., Linkesch, W., Cannell, P., Marcatti, M., Bay, J.-O., Rocha, V., Kröger, N., Gluckman, E., Olavarria, E., and Robin, M.

Published
2014

16. T CELL DEPLETED HAPLOIDENTICAL STEM CELL TRANSPLANTATION FOLLOWED BY ADD-BACKS OF SUICIDE-GENE MODIFIED DONOR T-CELLS OFFERS LONG TERM SURVIVAL FREE OF IMMUNE SUPPRESSION TREATMENT: A 7 YEARS FOLLOW-UP IN 56 PATIENTS: PH-O084

Author

Lupo-Stanghellini, M. T., Greco, R., Oliveira, G., Peccatori, J., Marcatti, M., Guggiari, E., Lunghi, F., Marktel, S., Giglio, F., Bondanza, A., Malerba, A., Trinca, S., Corti, C., Bernardi, M., Lambiase, A., Bordignon, C., Bonini, C., and Ciceri, F.

Published
2014

22. Treosulfan-based conditioning regimen allows an early full donor chimerism after related and unrelated transplant with low toxicity. Results from a prospective single-centre study: P972

Author

Lorusso, A., Crotta, A., Messina, C., Ruggeri, A., Forno, B., Marcatti, M., Clerici, D., Lupo Stanghellini, M. T., Giglio, F., Mastaglio, S., Forcina, A., Malato, S., Lunghi, F., Assanelli, A., Gattillo, S., Ronchi, P., Fleischhauer, K., Bernardi, M., Corti, C., Ciceri, F., and Peccatori, J.

Published
2011

29. Rapamycin-based GvHD prophylaxis after T-cell replete unmanipulated haploidentical peripheral stem cell transplantation for advanced leukaemias: preliminary results of the TrRaMM study: O171

Author

Peccatori, J., Clerici, D., Forcina, A., Messina, C., Stanghellini, Lupo M.T., Noviello, M., Valtolina, V., Giorgiani, G., Crocchiolo, R., Marcatti, M., Mastaglio, S., Assanelli, A., Guggiari, E., Crotta, A., Gattillo, S., Rossini, S., Corti, C., Bernardi, M., Locatelli, F., Bonini, C., and Ciceri, F.

Published
2009

32. Mitochondrial DNA damage and subsequent activation of Z-DNA binding protein 1 links oxidative stress to inflammation in epithelial cells

Author

Szczesny, B. Marcatti, M. Ahmad, A. Montalbano, M. Brunyánszki, A. Bibli, S.-I. Papapetropoulos, A. Szabo, C.

Abstract

This report identifies mitochondrial DNA (mtDNA) as a target and active mediator that links low-level oxidative stress to inflammatory response in pulmonary epithelial cells. Extrusion of mtDNA into the bronchoalveolar lavage fluid occurs as an early event in mice subjected to cigarette smoke injury, concomitantly with the depletion of mtDNA in the lung tissue. In cultured lung epithelial cells, prolonged, low-level oxidative stress damages the mtDNA, without any detectable damage to the nuclear DNA. In turn, cellular depletion of the mtDNA occurs, together with a transient remodeling of cellular bioenergetics and morphology - all without any detectable impairment in overall cell viability. Damaged mtDNA first enters the cytoplasm, where it binds to Z-DNA binding protein 1 (ZBP1) and triggers inflammation via the TANK-binding kinase 1 /interferon regulatory factor 3 signaling pathway. Fragments of the mtDNA are subsequently released into the extracellular space via exosomes. MtDNA-containing exosomes are capable of inducing an inflammatory response in naïve (non-oxidatively stressed) epithelial cells. In vivo, administration of isolated mtDNA into the in lungs of naïve mice induces the production of pro-inflammatory mediators, without histopathologic evidence of tissue injury. We propose that mtDNA-specific damage, and subsequent activation of the ZBP1 pathway, is a mechanism that links prolonged, low-level oxidative stress to autocrine and paracrine inflammation during the early stages of inflammatory lung disease. © 2018 The Author(s).

Published
2018

33. PF751 POST-TRANSPLANT CYCLOPHOSPHAMIDE AND SIROLIMUS IN HAPLOIDENTICAL TRANSPLANT WITH PBSC GRAFTS: RESULTS IN 151 PATIENTS

Author

Silani, M., primary, Greco, R., additional, Albanese, S., additional, Lorentino, F., additional, Stanghellini, M.T. Lupo, additional, Giglio, F., additional, Clerici, D., additional, Lazzari, L., additional, Serio, F., additional, Piemontese, S., additional, Marcatti, M., additional, Mastaglio, S., additional, Assanelli, A., additional, Corti, C., additional, Bernardi, M., additional, Peccatori, J., additional, and Ciceri, F., additional

Published
2019
Full Text
View/download PDF

34. The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Author

Frenquelli, M., primary, Caridi, N., additional, Antonini, E., additional, Storti, F., additional, Viganò, V., additional, Gaviraghi, M., additional, Occhionorelli, M., additional, Bianchessi, S., additional, Bongiovanni, L., additional, Spinelli, A., additional, Marcatti, M., additional, Belloni, D., additional, Ferrero, E., additional, Karki, S., additional, Brambilla, P., additional, Martinelli-Boneschi, F., additional, Colla, S., additional, Ponzoni, M., additional, DePinho, R. A., additional, and Tonon, G., additional

Published
2019
Full Text
View/download PDF

36. Treosulfan based reduced toxicity conditioning followed by allogeneic stem cell transplantation in patients with myelofibrosis

Author

Claudiani S., Marktel S., Piemontese S., Assanelli A., Lupo-Stanghellini M. T., Carrabba M., Guggiari E., Giglio F., De Freitas T., Marcatti M., Bernardi M., Corti C., Peccatori J., Lunghi F., Ciceri F., Claudiani, S., Marktel, S., Piemontese, S., Assanelli, A., Lupo-Stanghellini, M. T., Carrabba, M., Guggiari, E., Giglio, F., De Freitas, T., Marcatti, M., Bernardi, M., Corti, C., Peccatori, J., Lunghi, F., and Ciceri, F.

Subjects
Male, Transplantation Conditioning, bone marrow transplantation, Middle Aged, Allografts, Disease-Free Survival, Survival Rate, Primary Myelofibrosis, hematopoietic stem cell transplantation, reduced-toxicity conditioning, Humans, Female, myeloproliferative disease, Unrelated Donors, treosulfan, Busulfan, Vidarabine, Aged, Stem Cell Transplantation
Abstract

Allogeneic transplantation is the only potentially curative strategy for myelofibrosis, even in the era of new drugs that so far only mitigate symptoms. The choice to proceed to allogeneic transplantation is based on several variables including age, disease phase, degree of splenomegaly, donor availability, comorbidities and iron overload. These factors, along with conditioning regimen and time to transplantation, may influence the outcome of ASCT. We report 14 patients affected by myelofibrosis with a median age of 57 years (range, 41–76) receiving a treosulfan-fludarabine based reduced toxicity conditioning. Patients (pts) received a stem cell transplantation from an HLA identical (n = 10) or matched unrelated donor (n = 4). All pts had a complete myeloablation followed by engraftment and in 12 out of 13 evaluated pts donor chimerism was 100% at 1 month. In most cases a reduction of splenomegaly and a reduction (or resolution) of bone marrow fibrosis was observed. After a median follow-up of 39 months (range, 3–106), the 3-year probability of overall survival and disease free survival was 54 +/− 14% and 46 +/− 14%, respectively. The cumulative incidence of non-relapse mortality at 2 years was 39 +/− 15%. Causes of non-relapse mortality were: infection (n = 2), GvHD (n = 2) and haemorrhage (n = 1). We can conclude that a treosulfan and fludarabine based conditioning has a potent myeloablative and anti-disease activity although non-relapse mortality remains high in this challenging clinical setting. Copyright © 2014 John Wiley & Sons, Ltd.

Published
2016

37. T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus

Author

Greco R, Piemontese S, Cieri N, Giglio F, Morelli M, Messina C, Marcatti M, Marktel S, Carrabba M, Bernardi M, Corti C, Assanelli A, Stanghellini MTL, Bonini C, Vago L, Ciceri F, Peccatori J, Greco, R, Piemontese, S, Cieri, N, Giglio, F, Morelli, M, Messina, C, Marcatti, M, Marktel, S, Carrabba, M, Bernardi, M, Corti, C, Assanelli, A, Stanghellini, Mtl, Bonini, C, Vago, L, Ciceri, F, and Peccatori, J

Published
2016

38. Secondary solid tumors after allogeneic stem cell transplantation: active surveillance in long term follow-up

Author

Lupo-Stanghellini MT, Assanelli A, Greco R, Giglio F, Mastaglio S, Morelli M, Pavesi F, Sala E, Brambilla M, Piemontese S, Vago L, Messina C, Dalto SC, Francesca L, Perini T, Girlanda S, Malerba A, Marcatti M, Guggiari E, Marktel S, Carrabba M, Lunghi F, Bernardi M, Bonini C, Corti C, Peccatori J, Ciceri F, Lupo-Stanghellini, Mt, Assanelli, A, Greco, R, Giglio, F, Mastaglio, S, Morelli, M, Pavesi, F, Sala, E, Brambilla, M, Piemontese, S, Vago, L, Messina, C, Dalto, Sc, Francesca, L, Perini, T, Girlanda, S, Malerba, A, Marcatti, M, Guggiari, E, Marktel, S, Carrabba, M, Lunghi, F, Bernardi, M, Bonini, C, Corti, C, Peccatori, J, and Ciceri, F

Published
2016

39. Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients

Author

Barbanti MC, Greco R, Mancini N, Orsini A, Crucitti L, Forcina A, Lorentino F, Giglio F, Stanghellini MTL, Vago L, Morelli M, Girlanda S, Clerici D, Carrabba M, Marktel S, Assanelli A, Marcatti M, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Barbanti, Mc, Greco, R, Mancini, N, Orsini, A, Crucitti, L, Forcina, A, Lorentino, F, Giglio, F, Stanghellini, Mtl, Vago, L, Morelli, M, Girlanda, S, Clerici, D, Carrabba, M, Marktel, S, Assanelli, A, Marcatti, M, Bernardi, M, Corti, C, Peccatori, J, Clementi, M, and Ciceri, F

Published
2015

40. Second Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-based Conditioning Regimen for Acute Leukemia in Relapse

Author

Peccatori J, Crucitti L, Greco R, Stanghellini MTL, Vago L, Cieri N, Giglio F, Morelli M, Assanelli A, Marcatti M, Carrabba M, Marktel S, Perini T, Lorentino F, Girlanda S, Corti C, Bernardi M, Ciceri F, Peccatori, J, Crucitti, L, Greco, R, Stanghellini, Mtl, Vago, L, Cieri, N, Giglio, F, Morelli, M, Assanelli, A, Marcatti, M, Carrabba, M, Marktel, S, Perini, T, Lorentino, F, Girlanda, S, Corti, C, Bernardi, M, and Ciceri, F

Published
2015

41. Standardized care of long-term survivors after allogeneic stem cell transplantation: a cross-sectional 1-year evaluation in 249 adults

Author

Lupo-Stanghellini MT, Orsini A, Mastaglio S, Girlanda S, Perini T, Brambilla M, Tassara M, Lorentino F, Piemontese S, Forcina A, Vago L, Pavesi F, Sala E, Malerba A, Marcatti M, Guggiari E, Marktel S, Assanelli A, Carrabba M, Lunghi F, Bernardi M, Peccatori J, Corti C, Ciceri F, Lupo-Stanghellini, Mt, Orsini, A, Mastaglio, S, Girlanda, S, Perini, T, Brambilla, M, Tassara, M, Lorentino, F, Piemontese, S, Forcina, A, Vago, L, Pavesi, F, Sala, E, Malerba, A, Marcatti, M, Guggiari, E, Marktel, S, Assanelli, A, Carrabba, M, Lunghi, F, Bernardi, M, Peccatori, J, Corti, C, and Ciceri, F

Published
2015

43. Advances in pharmacotherapy for cardiac amyloidosis

Author

Spoladore, R., Falasconi, G., Marcatti, M., Di Maio, S., Fiore, G., Slavich, M., Margonato, A., Turco, A., and Fragasso, G.

Abstract

ABSTRACTIntroductionAmyloidosis is a group of progressive and devastating disorders resulting from extracellular deposition of misfolded proteins into tissues. When deposition of fibrils occurs in cardiac tissues, this systemic disease can lead to a very poor prognosis. Systemic amyloidosis can be acquired [light chain (AL) amyloidosis; AA amyloidosis], or hereditary [transthyretin (ATTR) amyloidosis]. Cardiac disease in amyloidosis is usually secondary to a systemic disease. The diagnosis of cardiac involvement is often delayed and yields an adverse prognosis.Areas coveredin this review, the authors report current literature on advances in pharmacotherapy for cardiac amyloidosis, mainly focused on AL and ATTR amyloidosis treatment.Expert opinionMost pharmacological trials in amyloidosis patients, both AL and TTR, are directed to study the effects of drugs on polyneuropathy. However, since cardiac involvement carries a prominent negative survival impact in amyloidosis patients, future research should be more focused on amyloidosis cardiomyopathy as primary endpoint. Additionally, in AL amyloidosis therapies are mainly derived from experience on multiple myeloma treatment. In this specific setting, possible future research could particularly focus on immunotherapeutic agents able to optimize the standard chemotherapy results and, thus, allowing a larger population of patients to be treated by bone marrow stem cell transplantation.

Published
2021
Full Text
View/download PDF

44. RAPID MOLECULAR DETECTION OF PATHOGENS IN 1941 BLOOD SAMPLES FROM 516 CONSECUTIVE PATIENTS WITH FEBRILE NEUTROPENIA

Author

Greco R, Mancini N, Lorentino F, Crucitti L, Barbanti MC, Forcina A, Orsini A, Vago L, Giglio F, Morelli M, Levati G, Sala E, Clerici D, Stanghellini MTL, Carrabba M, Marktel S, Assanelli A, Marcatti M, Bernardi M, Peccatori J, Corti C, Clementi M, Ciceri F, Greco, R, Mancini, N, Lorentino, F, Crucitti, L, Barbanti, Mc, Forcina, A, Orsini, A, Vago, L, Giglio, F, Morelli, M, Levati, G, Sala, E, Clerici, D, Stanghellini, Mtl, Carrabba, M, Marktel, S, Assanelli, A, Marcatti, M, Bernardi, M, Peccatori, J, Corti, C, Clementi, M, and Ciceri, F

Published
2014

45. Rapid Molecular Detection of Pathogens in 516 Consecutive Haematological Patients with Febrile Neutropenia

Author

Greco R, Barbanti MC, Mancini N, Crucitti L, Forcina A, Lorentino F, Orsini A, Vago L, Giglio F, Stanghellini MTL, Clerici D, Carrabba MG, Marktel S, Assanelli A, Marcatti M, Bernardi M, Corti C, Peccatori J, Clementi M, Ciceri F, Greco, R, Barbanti, Mc, Mancini, N, Crucitti, L, Forcina, A, Lorentino, F, Orsini, A, Vago, L, Giglio, F, Stanghellini, Mtl, Clerici, D, Carrabba, Mg, Marktel, S, Assanelli, A, Marcatti, M, Bernardi, M, Corti, C, Peccatori, J, Clementi, M, and Ciceri, F

Published
2014

46. ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING

Author

Giglio F, Brambilla CZ, Lorentino F, Piemontese S, Crucitti L, Greco R, Morelli M, Messina C, Forcina A, Stanghellini MTL, Vago L, Marktel S, Marcatti M, Assanelli A, Corti C, Bernardi M, Bonini C, Ciceri F, Peccatori J, Giglio, F, Brambilla, Cz, Lorentino, F, Piemontese, S, Crucitti, L, Greco, R, Morelli, M, Messina, C, Forcina, A, Stanghellini, Mtl, Vago, L, Marktel, S, Marcatti, M, Assanelli, A, Corti, C, Bernardi, M, Bonini, C, Ciceri, F, and Peccatori, J

Published
2014

47. Haploidentical Hematopoietic Stem Cell Transplantation with Treosulfan-Based Conditioning Regimen for Acute Leukemia Relapsing after Initial Allogeneic Transplantation

Author

Peccatori J, Crucitti L, Greco R, Stanghellini MTL, Vago L, Cieri N, Brambilla CZ, Giglio F, Morelli M, Assanelli A, Marcatti M, Carrabba MG, Bonini C, Bernardi M, Ciceri F, Peccatori, J, Crucitti, L, Greco, R, Stanghellini, Mtl, Vago, L, Cieri, N, Brambilla, Cz, Giglio, F, Morelli, M, Assanelli, A, Marcatti, M, Carrabba, Mg, Bonini, C, Bernardi, M, and Ciceri, F

Published
2014

48. VORICONAZOLE PROPHYLAXIS OF INVASIVE FUNGAL INFECTION IN HAPLOIDENTICAL ALLOGENIC STEM CELL TRANSPLANTATION

Author

Sarghi S, Lorentino F, Giglio F, Brambilla CZ, Crucitti L, Levati G, Greco R, Messina C, Forcina A, Stanghellini MTL, Vago L, Marktel S, Marcatti M, Assanelli A, Bernardi M, Peccatori J, Corti C, Ciceri F, Sarghi, S, Lorentino, F, Giglio, F, Brambilla, Cz, Crucitti, L, Levati, G, Greco, R, Messina, C, Forcina, A, Stanghellini, Mtl, Vago, L, Marktel, S, Marcatti, M, Assanelli, A, Bernardi, M, Peccatori, J, Corti, C, and Ciceri, F

Published
2014

49. HUMAN HERPES VIRUS 6 AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

Author

Greco R, Lorentino F, Crucitti L, Vago L, Stanghellini MTL, Forcina A, Giglio F, Morelli M, Levati G, Orsini A, Carbone MR, Valtolina V, Noviello M, Marktel S, Assanelli A, Carrabba M, Marcatti M, Peccatori J, Bernardi M, Bonini C, Corti C, Ciceri F, Greco, R, Lorentino, F, Crucitti, L, Vago, L, Stanghellini, Mtl, Forcina, A, Giglio, F, Morelli, M, Levati, G, Orsini, A, Carbone, Mr, Valtolina, V, Noviello, M, Marktel, S, Assanelli, A, Carrabba, M, Marcatti, M, Peccatori, J, Bernardi, M, Bonini, C, Corti, C, and Ciceri, F

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results